Make Better Decisions - Finding and Evaluating Generic and Branded Drug Market Entry Opportunities

Get the Book: Make Better Decisions

Finding and Evaluating Generic and Branded Drug Market Entry Opportunities

PDF eBook: Just $10 Get Print Book on Amazon

Serving leading biopharmaceutical companies globally:

Express Scripts
McKesson
McKinsey
Mallinckrodt
Colorcon
Dow

Last Updated: October 24, 2019

DrugPatentWatch Database Preview

Sargramostim - Biologic Drug Details

See Plans and Pricing

« Back to Dashboard

Summary for sargramostim
Tradenames:1
Patents:111
Applicants:1
BLAs:1
Suppliers: see list2
Patent Litigation and PTAB cases: See patent lawsuits and PTAB cases for sargramostim
Recent Litigation for sargramostim

Identify key patents and potential future biosimilar entrants

District Court Litigation
Case NameDate
Amgen Inc. v. Accord Healthcare, Inc.2018-06-28
Village at Camp Bowie I, L.P.2010-08-02

See all sargramostim litigation

US Patents for sargramostim

Applicant Tradename Biologic Ingredient Dosage Form BLA Number Approval Date Patent No. Assignee Estimated Patent Expiration Status Orphan Source
Berlex Labs LEUKINE sargramostim VIAL 103362 001 1991-03-05   Start Trial SIO2 MEDICAL PRODUCTS, INC. (Auburn, AL) 2033-03-11 RX search
Berlex Labs LEUKINE sargramostim VIAL 103362 001 1991-03-05   Start Trial YALE UNIVERSITY (New Haven, CT) 2021-05-01 RX search
Berlex Labs LEUKINE sargramostim VIAL 103362 001 1991-03-05   Start Trial University of the Sciences of Philadelphia (Philadelphia, PA) 2034-11-21 RX search
>Applicant >Tradename >Biologic Ingredient >Dosage Form >BLA >Number >Approval Date >Patent No. >Assignee >Estimated Patent Expiration >Status >Orphan >Source

Supplementary Protection Certificates for sargramostim

Supplementary Protection Certificate SPC Country SPC Expiration SPC Description
0687 Netherlands   Start Trial PRODUCT NAME: SILTUXIMAB; REGISTRATION NO/DATE: EU/1/14/928/001-002 20140527
14/048 Ireland   Start Trial PRODUCT NAME: SILTUXIMAB; REGISTRATION NO/DATE: EU/1/14/928/001-002 20140522
00687 Netherlands   Start Trial PRODUCT NAME: SILTUXIMAB; REGISTRATION NO/DATE: EU/1/14/928/001-002 20140522
>Supplementary Protection Certificate >SPC Country >SPC Expiration >SPC Description

Make Better Decisions: Try a trial or see plans & pricing

Serving leading biopharmaceutical companies globally:

Baxter
McKesson
Colorcon
Johnson and Johnson
Merck
Express Scripts

Drugs may be covered by multiple patents or regulatory protections. All trademarks and applicant names are the property of their respective owners or licensors. Although great care is taken in the proper and correct provision of this service, thinkBiotech LLC does not accept any responsibility for possible consequences of errors or omissions in the provided data. The data presented herein is for information purposes only. There is no warranty that the data contained herein is error free. thinkBiotech performs no independent verifification of facts as provided by public sources nor are attempts made to provide legal or investing advice. Any reliance on data provided herein is done solely at the discretion of the user. Users of this service are advised to seek professional advice and independent confirmation before considering acting on any of the provided information. thinkBiotech LLC reserves the right to amend, extend or withdraw any part or all of the offered service without notice.